{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:50:22Z","timestamp":1790351422520,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 GM135930"],"award-info":[{"award-number":["R01 GM135930"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007161","name":"Boston University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007161","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CCF-2200052"],"award-info":[{"award-number":["CCF-2200052"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMS-1664644"],"award-info":[{"award-number":["DMS-1664644"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["IIS-1914792"],"award-info":[{"award-number":["IIS-1914792"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL54 TR004130"],"award-info":[{"award-number":["UL54 TR004130"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","award":["N00014-19-1-2571"],"award-info":[{"award-number":["N00014-19-1-2571"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.leukres.2024.107502","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T15:36:27Z","timestamp":1713195387000},"page":"107502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Prediction of deep molecular response in chronic myeloid leukemia using supervised machine learning models"],"prefix":"10.1016","volume":"141","author":[{"given":"Zahra","family":"Zad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Bonecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Zalcberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo T.","family":"Stelzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Sabioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Mayumi","family":"Gutiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia L.","family":"Fleck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis Ch.","family":"Paschalidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.leukres.2024.107502_bib1","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"Nowell","year":"1960","journal-title":"JNCI\u00a0J. Natl. Cancer Inst."},{"issue":"6020","key":"10.1016\/j.leukres.2024.107502_bib2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/315550a0","article-title":"Fused transcript of abl and bcr genes in chronic myelogenous leukaemia","volume":"315","author":"Shtivelman","year":"1985","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.leukres.2024.107502_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3324\/haematol.2015.139337","article-title":"Chronic myeloid leukemia: reminiscences and dreams","volume":"101","author":"Mughal","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2024.107502_bib4","unstructured":"D. Vasella, R. Slater, Magic Cancer Bullet: How A Tiny Orange Pill Is Rewriting Medical History, 2003, vii, 258-vii, 258."},{"issue":"5","key":"10.1016\/j.leukres.2024.107502_bib5","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3324\/haematol.2018.206797","article-title":"Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV","volume":"104","author":"Michel","year":"2019","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.leukres.2024.107502_bib6","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3324\/haematol.2019.222216","article-title":"Discontinuation of tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia \u2013 you can do this at home if you read the instructions","volume":"104","author":"Schiffer","year":"2019","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.leukres.2024.107502_bib7","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","article-title":"European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia","volume":"34","author":"Hochhaus","year":"2020","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.leukres.2024.107502_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00994018","article-title":"Support-vector networks","volume":"20","author":"Cortes","year":"1995","journal-title":"Mach. Learn."},{"issue":"1-2","key":"10.1016\/j.leukres.2024.107502_bib9","first-page":"1","article-title":"Distributionally robust learning","volume":"4","author":"Chen","year":"2020","journal-title":"OPT"},{"key":"10.1016\/j.leukres.2024.107502_bib10","unstructured":"G. Ke, Q. Meng, T. Finley, , LightGBM: A Highly Efficient Gradient Boosting Decision Tree, NIPS, 2017."},{"issue":"1","key":"10.1016\/j.leukres.2024.107502_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach. Learn."},{"key":"10.1016\/j.leukres.2024.107502_bib12","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1038\/s41375-022-01607-z","article-title":"Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study","volume":"36","author":"White","year":"2022","journal-title":"Leukemia"},{"issue":"15","key":"10.1016\/j.leukres.2024.107502_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015222","article-title":"Predictive value of early molecular response for deep molecular response in chronic phase of chronic myeloid leukemia","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.leukres.2024.107502_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1200\/JCO.2013.49.9020","article-title":"Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV","volume":"32","author":"Hehlmann","year":"2014","journal-title":"JCO"},{"issue":"Supplement_1","key":"10.1016\/j.leukres.2024.107502_bib15","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1182\/blood-2019-131272","article-title":"Generic versus branded imatinib as frontline therapy in chronic-phase chronic myeloid leukemia patients in Italy: a case-control study","volume":"134","author":"Bonifacio","year":"2019","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2024.107502_bib16","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1182\/blood-2010-12-319038","article-title":"Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score","volume":"118","author":"Hasford","year":"2011","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2024.107502_bib17","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood.2020005514","article-title":"Early BCR-ABL1 kinetics are predictive of subsequent achievement of treatment-free remission in chronic myeloid leukemia","volume":"137","author":"Shanmuganathan","year":"2021","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624000687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624000687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T12:25:08Z","timestamp":1716899108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212624000687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":17,"alternative-id":["S0145212624000687"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107502","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of deep molecular response in chronic myeloid leukemia using supervised machine learning models","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107502","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107502"}}